Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.32 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.32 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.32 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.32 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | OTC | P00480 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15199764 | 0.85 | BLM (0.40) | KDM1ABLMLTA4HGABRR1CYP1A2 | |
| SCHEMBL18071127 | 0.82 | KDM1A (0.51) | KDM1ABLMCYP1A2MEN1KMT2A | |
| SCHEMBL4407451 | 0.82 | KDM1A (0.51) | KDM1ABLMCYP1A2MEN1KMT2A | |
| SCHEMBL13485480 | 0.82 | KDM1A (0.51) | KDM1ABLMCYP1A2MEN1KMT2A | |
| SCHEMBL14842600 | 0.82 | KDM1A (0.51) | KDM1ABLMCYP1A2MEN1KMT2A | |
| SCHEMBL21196892 | 0.82 | KDM1A (0.51) | KDM1AMEN1KMT2AGAASCN5A | |
| SCHEMBL22509292 | 0.82 | KDM1A (0.51) | KDM1AMEN1KMT2AGAASCN5A | |
| SCHEMBL21195165 | 0.82 | KDM1A (0.51) | KDM1ABLMCYP1A2MEN1KMT2A | |
| SCHEMBL287988 | 0.82 | KDM1A (0.51) | KDM1ABLMCYP1A2MEN1KMT2A | |
| SCHEMBL25983177 | 0.80 | KDM1A (0.62) | KDM1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10717787-B1 | Antibodies to symmetrically dimethylated arginine analytes and use thereof | ARK DIAGNOSTICS, INC. (US) | 2020-07-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10717787-B1 | Antibodies to symmetrically dimethylated arginine analytes and use thereof | PRMT3, PRMT5, PRMT1 | KDM1A 881/4885BLM 3996/4885LTA4H 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.